These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Genetic defects in control of T cell activation evolving in a syndrome of lymphohistiocytic activation]. Dufourcq-Lagelouse R; Pastural E; Barrat FJ; Le Deist F; Fischer A; de Saint Basile G Arch Pediatr; 1999; 6 Suppl 2():417s-419s. PubMed ID: 10370555 [No Abstract] [Full Text] [Related]
9. Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Eife R; Janka GE; Belohradsky BH; Holtmann H Pediatr Hematol Oncol; 1989; 6(3):265-72. PubMed ID: 2642085 [No Abstract] [Full Text] [Related]
10. CT and MR findings in familial erythrophagocytic lymphohistiocytosis. Huddle DC; Rosenblum JD; Diamond CK AJR Am J Roentgenol; 1994 Jun; 162(6):1504-5. PubMed ID: 8192058 [No Abstract] [Full Text] [Related]
12. Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy. Ware R; Friedman HS; Kinney TR; Kurtzberg J; Chaffee S; Falletta JM Med Pediatr Oncol; 1990; 18(1):27-9. PubMed ID: 2294389 [No Abstract] [Full Text] [Related]
13. Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? Schneider EM; Lorenz I; Walther P; Janka-Schaub GE J Pediatr Hematol Oncol; 2003 Sep; 25(9):680-3. PubMed ID: 12972801 [No Abstract] [Full Text] [Related]